For most patients, the established benefits of GLP-1 therapy in managing diabetes and obesity far outweigh theoretical concerns about pancreatic cancer that have not been supported by current evidence
Dual agonism at the amylin receptor (a heterodimer of calcitonin receptor + RAMP1/2/3) and the calcitonin receptor in area postrema and arcuate nucleus, reducing food intake and promoting satiety
El estudio confirma que, en algunos casos, pueden causar problemas gastrointestinales, como nuseas y vmitos
Your care team may suggest alternative GLP-1 formulations, dose frequencies, or management strategies tailored to your lifestyle
It helps reduce appetite, improve metabolism, and increase energy expenditure all under medical supervision at Healthy Balance
This product should not be used as a substitute for a varied and balanced diet and healthy lifestyle